Bryanbryoil
Pray For Ukraine
- Sep 13, 2004
- 86,179
- 34,558
My work (city hall) is staying at 35 percent capacity till there is a vaccine. I’m ok with it. Small tight offices, I don’t want a bunch of people around lol.Ive been trying to stay optimistic about it, but Johnson & Johnson just had a hiccup delaying their progress, maybe easter they might have something approved
https://nypost.com/2020/10/14/cuomo-says-ny-hospitals-were-never-overwhelmed-at-covid-19-peak/
You mean the media was simply creating fear?
Shocking
Something wrong with this picture.
Cuomo says no but Doctors and Nurses say yes.
“He was working on his truck the day before he passed away. So it’s not like he was incapacitated, lying in bed,” Archbold said.
https://nypost.com/2020/10/14/cuomo-says-ny-hospitals-were-never-overwhelmed-at-covid-19-peak/
You mean the media was simply creating fear?
Shocking
Yeah, how does that change what Cuomo said?Isn't that a tabloid?
She never mentioned once the hospitals being overwhelmed in that video
Very sad..still doesn’t say the hospitals were overwhelmed
Very sad..still doesn’t say the hospitals were overwhelmed
Very sad..still doesn’t say the hospitals were overwhelmed
Yeah, how does that change what Cuomo said?
End of October in USA, when in Canada?We may be barreling towards a fight between the FDA and White House over the vaccine approval.
The FDA revised their guidance for vaccine approval about a week ago in response to the political threat of any candidate being approved prematurely for election purposes. The non-binding guidance spells out that 2 months of safety data after the 2nd dose will be required as part of the data packet submitted to the regulatory body. This would allow vaccine developers to provide a stronger, evidenced-based argument to the review panels. In addition, it should strengthen the public's confidence in receiving the vaccine, which was eroding after the vaccine became a political issue. However, this would push earliest approval in November/December territory.
That being said... Pfizer has jumped into the lead because they applied their established, vast trial recruitment network to enroll the required number of people into the study the fastest among the competitors. They still claim that they will have the efficacy data by the end of October, but have been tight-lipped about whether they would support political intervention by the White House to approve the vaccine without the additional 2 months of safety data should that option be presented to them.